Dow Jones

40 211,72

0,53%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
30/08/2021	14h00	Business Wire	Showcasing Teva’s Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/08/2021	12h11	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
20/08/2021	14h00	Business Wire	Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
19/08/2021	22h04	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
12/08/2021	22h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/07/2021	22h11	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/07/2021	13h30	Business Wire	Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/07/2021	13h00	Business Wire	Teva Reports Second Quarter 2021 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/07/2021	14h00	Business Wire	Teva Announces Changes to Executive Management Team	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/07/2021	18h14	Business Wire	Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/06/2021	11h09	TipRanks	Teva, Bioeq Partner to Sell Lucentis Biosimilar	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/06/2021	19h39	Business Wire	Teva und Bioeq geben Vertriebspartnerschaft für Biosimilar bekannt	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/06/2021	17h46	Business Wire	Teva et Bioeq annoncent un partenariat commercial dans le domaine des biosimilaires	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
28/06/2021	14h00	Business Wire	Teva and Bioeq Announce Commercial Partnership for Biosimilar	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/06/2021	14h12	Business Wire	Teva Announces Ministry of Health, Labour & Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Tre...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/06/2021	08h58	Business Wire	Nouvelles données relatives à l'innocuité du traitement par COPAXONE® (acétate de glatiramère) chez les mères allaitan...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	23h18	Business Wire	Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to T...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	16h36	Business Wire	Neue Sicherheitsdaten zur Behandlung von stillenden Müttern mit COPAXONE® (Glatirameracetat), die mit schubförmig verlaufe...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	10h17	Business Wire	Teva présente de nouvelles données lors du 7e congrès de l’Académie européenne de neurologie, suggérant que des facte...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	08h30	Business Wire	New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple S...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	07h24	Business Wire	Teva präsentiert neue Daten auf dem 7. Kongress der European Academy of Neurology, die sozioökonomische Faktoren mit einer ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	04h55	Business Wire	De nouvelles données étayant le profil d’innocuité et d’efficacité d’AJOVY® (frémanezumab) partagées lors du 7e ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/06/2021	04h54	Business Wire	Neue Daten, die das Sicherheits- und Wirksamkeitsprofil von AJOVY® (Fremanezumab) stützen, werden auf dem 7. Kongress der E...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/06/2021	14h01	Business Wire	Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the ...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/06/2021	14h01	Business Wire	New Data Supporting the Safety & Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congr...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
16/06/2021	13h36	Business Wire	Teva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of Rosacea	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/06/2021	14h15	Business Wire	New Clinical & Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at 2021 American Headac...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
03/06/2021	14h00	Business Wire	Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeti...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/05/2021	19h03	Business Wire	Teva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tablets	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
17/05/2021	14h00	PR Newswire (US)	Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia an...	NYSE:TEVA	Teva Pharmaceutical Industries Ltd